Why the study?
Does the extent of tumour thrombus predict disease recurrence in patients undergoing surgical resection for renal cell carcinoma with inferior vena cava involvement?
Does the extent of tumour thrombus predict disease recurrence in patients undergoing surgical resection for renal cell carcinoma with inferior vena cava involvement?
Answers are grounded in this paper and cite their sources.
In patients with locally advanced RCC and IVC thrombus, supra-diaphragmatic extension is a significant predictor of disease recurrence, highlighting the need for effective adjuvant therapies.
OBJECTIVE To evaluate our experience with surgical resection of renal cell carcinoma (RCC) with inferior vena cava (IVC) involvement and examine the relationship between prognosis and tumour extent. PATIENTS AND METHODS A retrospective review of nephrectomy performed between 1985 and 2005 identified 50 patients presenting with tumour thrombus extension into the IVC. Clinical characteristics and outcome were evaluated. RESULTS Of the 50 patients evaluated, 7, 26, 10 and 7 presented with level I, II, III and IV thrombus, respectively. Major postoperative complications occurred in 16% of patients. Local or distant failure occurred in 25 (64%) patients. The mean time to recurrence was 10 months. Only supra‐diaphragmatic extension of the tumour thrombus was predictive of disease recurrence. CONCLUSION Locally advanced RCC with IVC thrombus remains associated with significant local and distant failure rate. The level of thrombus extension is significantly associated with disease recurrence. Effective adjuvant therapy is needed to improve outcome in this patient population.
No takes yet. Share an insight, caveat, or question.
Otaibi et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: